GGrantIndex
Sort

35,931 grants matching parkinsons

A NOVEL P11 PATHWAY AS A THERAPEUTIC TARGET FOR PARKINSON'S DISEASE

$5,915,000
Rockefeller University · · FY2009 · Department of Defense

Center without Walls for Imaging Proteinopathies with PET

$5,910,871
Robert H Mach · University Of Pennsylvania · U19 · FY2025 · NS

Establish a Public Private Partnership for COVID19 Research

$5,898,134
David N. Wholley · Foundation For The Nih · OT2 · FY2021 · OD

Effects of Coenzyme Q10 in Parkinson Disease-Phase 3

$5,777,812
M Flint Beal · Weill Medical Coll Of Cornell Univ · U01 · FY2009 · NS

Blood amyloid-beta relationship with amyloid plaques and CSF amyloid-beta

$5,694,699
Randall J Bateman · Washington University · RF1 · FY2019 · AG

Alzheimer's Gut Microbiome Project

$5,690,172
Rima F Kaddurah-Daouk · Duke University · U19 · FY2019 · AG

BRAIN CONNECTS: Center for a pipeline of high throughput integrated volumetric electron microscopy for whole mouse brain connectomics

$5,648,698
Nuno Macarico Da Costa · Allen Institute · UM1 · FY2024 · NS

Clinical and biomarker studies in Alzheimer's disease and related disorders

$5,587,710
Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2023 · AG

Sphingolipid Biology of Neurodegeneration

$5,572,752
Richard Proia · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK

Alzheimer's Gut Microbiome Project

$5,424,083
Rima F Kaddurah-Daouk · Duke University · U19 · FY2020 · AG

Scanning Probe Microscopy for the Intramural Research Community

$5,358,669
Emilios K Dimitriadis · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2023 · EB

Creating a Specialized Technological center for Assistive Rehabilitation Research (STAR)

$5,352,100
Lara A Thompson · University Of The District Of Columbia · C06 · FY2020 · OD

Phase 3 trial of inosine for Parkinson's disease CCC

$5,334,882
Michael A Schwarzschild · Massachusetts General Hospital · U01 · FY2016 · NS

Alzheimer's Gut Microbiome Project

$5,321,511
Rima F Kaddurah-Daouk · Duke University · U19 · FY2021 · AG

Acquisition of a 900 MHz NMR Spectrometer

$5,311,284
Massachusetts Institute Of Technology · P41 · FY2002 · GM

Alzheimer's Gut Microbiome Project

$5,306,873
Rima F Kaddurah-Daouk · Duke University · U19 · FY2022 · AG

Bridge2AI: Voice as a Biomarker of Health - Building an ethically sourced, bioaccoustic database to understand disease like never before

$5,302,032
Yael Emilie Bensoussan · University Of South Florida · OT2 · FY2023 · OD

Studies in Dementia and Neurodegenerative Diseases

$5,296,136
Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2017 · AG

Stem Cell Translation Laboratory (SCTL)

$5,256,473
Ilyas Singec · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR

Digital Health Technologies for Monitoring Motor Function in Progressive Supranuclear Palsy and Dementia with Lewy Bodies

$5,174,076
Ashkan Vaziri · Biosensics, Llc · UF1 · FY2025 · AG

Genetic and epigenetic regulation of retinal development, aging and evolution

$5,173,977
Anand Swaroop · National Eye Institute · ZIA · FY2022 · EY

Human Biochemical Genetics

$5,173,827
William Gahl · National Human Genome Research Institute · ZIA · FY2021 · HG

Phase 3 trial of inosine for Parkinson's disease CCC

$5,170,824
Michael A Schwarzschild · Massachusetts General Hospital · U01 · FY2015 · NS

Center for Alzheimer's and Related Dementias: First stage single-cell brain resource for Alzheimer's disease and related dementias

$5,151,546
Mark Cookson · National Institute On Aging · ZIA · FY2025 · AG

NDC for the Optical Control of Biological Function

$5,039,000
Ehud Isacoff · University Of California Berkeley · PN2 · FY2010 · EY